Liyuan Sun

ORCID: 0000-0003-2043-2911 · 14 papers in corpus
other 2025
Frontiers in immunology ·doi:10.3389/fimmu.2025.1748838

[This corrects the article DOI: 10.3389/fimmu.2023.1115504.].

lab-animal 2025
Stem cells translational medicine ·doi:10.1093/stcltm/szae079

Endometriosis is a chronic inflammatory and neoangiogenic disease. Endostatin is one of the most effective inhibitors of angiogenesis. Mesenchymal stem cells (MSCs) have been investigated as compelling options for cell therapy. However, the…

lab-animal 2024
Journal of molecular medicine (Berlin, Germany) ·doi:10.1007/s00109-024-02483-z

Endometriosis is a multifactorial gynecological disease, with angiogenesis as a key hallmark. The role of exosomal microRNAs (miRNAs) in endometriosis is not well understood. This study investigates differentially expressed exosomal miRNAs …

lab-animal 2024
·doi:10.21203/rs.3.rs-4509482/v1

Abstract Background: N6-methyladenosine(m6A) modification regulates the processes of RNA splicing, subcellular localization, translation and stability by changing the RNA structure and the interaction between RNA and RNA-binding proteins to…

2023
·doi:10.21203/rs.3.rs-3003927/v1

Abstract Background N6-methyladenosine(m6A) modification regulates the processes of RNA splicing, subcellular localization, translation and stability by changing the RNA structure and the interaction between RNA and RNA-binding proteins to …

other 2023
Journal of immunology research ·doi:10.1155/2023/2975581

BACKGROUND: Endometriosis is an inflammatory gynecological disease leading to deep pelvic pain, dyspareunia, and infertility. The pathophysiology of endometriosis is complex and depends on a variety of biological processes and pathways. The…

lab-animal 2023
Journal of translational medicine ·doi:10.1186/s12967-023-04209-0

BACKGROUND: Endometriosis (EMs), the ectopic planting of functional endometrium outside of the uterus, is a leading cause of infertility and pelvic pain. As a fundamental mRNA modification, N6-methyladenosine (m6A) participates in various p…

lab-animal 2023
Frontiers in immunology ·doi:10.3389/fimmu.2023.1115504

BACKGROUND: Endometriosis (EM) is a benign, multifactorial, immune-mediated inflammatory disease that is characterized by persistent activation of the NF-κB signaling pathway and some features of malignancies, such as proliferation and lymp…

lab-animal 2022
DNA and cell biology ·doi:10.1089/dna.2021.1017

Endometriosis is a benign gynecological disease sharing several features with malignant tumor. Cytoplasmic polyadenylation element-binding protein 3 (CPEB3), a potential target of miR-21-5p, is downregulated in endometriotic specimens. Howe…

lab-animal 2022
BMC molecular and cell biology ·doi:10.1186/s12860-022-00426-5

BACKGROUND: Endometriosis is one of the most common gynecological diseases, and seriously reduces the quality of life of patients. However, the pathogenesis of this disease is unclear. Therefore, more studies are needed to elucidate its pat…

other 2021
Frontiers in molecular biosciences ·doi:10.3389/fmolb.2021.743012

Background: Endometriosis is a serious gynecological disorder characterized by debilitating pain, infertility and the establishment of innervated endometriosis lesions outside the uterus. Early detection and accurate diagnosis are pivotal i…

other 2021
Frontiers in molecular biosciences ·doi:10.3389/fmolb.2020.614427

Background: Endometriosis is interpreted as the existence of endometrium outside the uterine cavity, such as ovaries, fallopian tubes and pelvic cavity. Dysmenorrhea, abnormal menstruation, infertility, and chronic pelvic pain are the prima…

other 2018
Fertility and sterility ·doi:10.1016/j.fertnstert.2018.02.138

OBJECTIVE: To investigate the abnormal expression of sonic hedgehog (SHH) signaling molecules in 52 eutopic endometrial tissues and its diagnostic potency in endometriosis. DESIGN: Retrospective study. SETTING: University hospital. PATIE…

lab-animal 2017
Stem cells international ·doi:10.1155/2017/4794827

Human endometrial tissue has become an attractive source of mesenchymal stem cells (MSCs) for cell-based therapies because these MSCs can be easily harvested and have tumour tropism as well as reduced immunogenic and inflammatory properties…